文献速递肝病消化道肿瘤与早癌

纵向甲胎蛋白筛查算法在慢性乙型肝炎患者中检测早期肝细胞癌

Detecting Early Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Using Longitudinal α-Fetoprotein Screening.
PubMed 文献 · Clin Gastroenterol Hepatol · 2022-08-27

本研究纳入588例慢性乙型肝炎患者,每至少6个月检测血清甲胎蛋白(AFP)并联合超声或CT/MRI筛查,比较参数经验贝叶斯(PEB)纵向AFP算法与固定阈值AFP监测的性能。中位随访52.7个月期间62例(10.5%)发生肝细胞癌(HCC),55例(88.7%)为巴塞罗那临床肝癌分期0或A期。PEB算法在患者水平真阳性率对筛查水平假阳性率的ROC曲线下面积显著高于单用AFP(0.94 vs 0.86,P < .0005),结论认为纵向PEB评估AFP较单用AFP改善了HCC筛查性能。

要点

  • PEB纵向AFP算法在慢性乙型肝炎患者中筛查HCC的AUC为0.94,高于单用AFP的0.86(P < .0005)。
  • 在80%特异度下,PEB算法较单用AFP提高HCC诊断前2年内患者水平真阳性率(80.6% vs 67.7%,P = .0485;校正后P = .1663)。
  • 中位随访52.7个月,62例(10.5%)发生HCC,其中55例(88.7%)为巴塞罗那临床肝癌分期0或A期。

核心结论

  • 在乙型肝炎患者中,采用PEB算法纵向评估AFP较单用AFP改善了HCC筛查性能。
  • 该算法可能在不增加患者额外费用或不便的情况下改善HCC筛查。

研究设计与样本

  • 研究测量了588例患者的血清AFP。
  • 患者至少每6个月接受一次AFP联合超声或计算机断层扫描/磁共振成像筛查。
  • PEB算法中调整了年龄、天冬氨酸氨基转移酶水平、丙氨酸氨基转移酶水平、血小板计数、总胆红素、凝血酶原时间和乙型肝炎病毒DNA水平。
  • 所有变量在病例确诊HCC时或对照末次随访时以及在第-6、-12、-18、-24、-30、-36、-42、-48和-54个月、直至第-60个月时采集。

主要发现

  • 中位随访52.7个月期间,共62例(10.5%)发生HCC。
  • 55例(88.7%)病例在巴塞罗那临床肝癌分期0或A期被检出。
  • 患者水平真阳性率对筛查水平假阳性率的ROC曲线下面积在PEB算法中显著高于单用AFP(0.94 vs 0.86;P < .0005)。
  • 在80%特异度下,PEB算法较单用AFP显著提高HCC诊断前2年内患者水平真阳性率(80.6% vs 67.7%;P = .0485;校正后P = .1663)。
  • PEB算法更有效地实现了首次阳性筛查。

关键数值与推荐

  • 在80%特异度下,PEB算法患者水平真阳性率80.6% vs 单用AFP 67.7%(P = .0485;校正后P = .1663)。
  • PEB算法AUC 0.94 vs 单用AFP 0.86(P < .0005)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: This study aimed to evaluate the parametric empirical Bayes (PEB) longitudinal α-fetoprotein (AFP) screening algorithm performance in patients with hepatitis B compared with AFP surveillance with a fixed threshold. METHODS: The serum AFP of 588 patients was measured. Patients were screened at least once every 6 months with AFP and ultrasound or computed tomography/magnetic resonance imaging. Age, aspartate aminotransferase level, alanine aminotransferase level, platelet count, total bilirubin, prothrombin time, and hepatitis B virus DNA level were adjusted in the PEB algorithm. All variables were abstracted at the time of hepatocellular carcinoma (HCC) diagnosis for cases or last follow-up for controls and at months -6, -12, -18, -24, -30, -36, -42, -48, and -54, up to month -60. RESULTS: Overall, 62 (10.5%) HCC cases developed during a median follow-up of 52.7 months. Moreover, 55 (88.7%) cases were detected at Barcelona Clinic Liver Cancer stage 0 or A. The area under the receiver-operating characteristic curve of the patient-level true positive rate against the screening-level false positive rate was significantly higher in the PEB algorithm than that in AFP alone (area under the receiver-operating characteristic curve: 0.94 vs 0.86; P < .0005). At 80% specificity, the PEB algorithm significantly improved the patient-level true positive rate within 2 years prior to HCC diagnosis compared with AFP alone (80.6% vs 67.7%, respectively; P = .0485; adjusted P = .1663). The PEB algorithm more effectively enabled first positive screening. CONCLUSIONS: The longitudinal assessment of AFP by the PEB algorithm improved HCC screening performance compared to AFP alone in patients with hepatitis B. This algorithm may improve HCC screening without additional cost or inconvenience to patients.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Choi J, Tayob N, Lim YS, et al. Detecting Early Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Using Longitudinal α-Fetoprotein Screening. Clin Gastroenterol Hepatol. 2022. PMID: 36031091. doi:10.1016/j.cgh.2022.08.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。